NDC 64764-335

KAZANO

Alogliptin And Metformin Hydrochloride

KAZANO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Alogliptin Benzoate; Metformin Hydrochloride.

Product ID64764-335_02798523-c270-4fb1-a819-c7e94de43443
NDC64764-335
Product TypeHuman Prescription Drug
Proprietary NameKAZANO
Generic NameAlogliptin And Metformin Hydrochloride
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2013-01-25
Marketing CategoryNDA / NDA
Application NumberNDA203414
Labeler NameTakeda Pharmaceuticals America, Inc.
Substance NameALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
Active Ingredient Strength13 mg/1; mg/1
Pharm ClassesDipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC],Biguanide [EPC],Biguanides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 64764-335-01

4 CARTON in 1 TRAY (64764-335-01) > 1 BLISTER PACK in 1 CARTON > 14 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Start Date2013-01-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64764-335-01 [64764033501]

KAZANO TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA203414
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-01-25

NDC 64764-335-60 [64764033560]

KAZANO TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA203414
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-01-25

NDC 64764-335-80 [64764033580]

KAZANO TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA203414
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-01-25

NDC 64764-335-77 [64764033577]

KAZANO TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA203414
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-01-25

Drug Details

Active Ingredients

IngredientStrength
ALOGLIPTIN BENZOATE12.5 mg/1

OpenFDA Data

SPL SET ID:83cb7914-a683-47bb-a713-f2bc6a596bd2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1368392
  • 1368391
  • 1368398
  • 1368385
    • UPC Code
  • 0364764335601
  • 0364764337605

    • Pharmacological Class

    • Dipeptidyl Peptidase 4 Inhibitors [MoA]
    • Dipeptidyl Peptidase 4 Inhibitor [EPC]
    • Biguanide [EPC]
    • Biguanides [CS]

    Medicade Reported Pricing

    64764033560 KAZANO 12.5-500 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "KAZANO" or generic name "Alogliptin And Metformin Hydrochloride"

    NDCBrand NameGeneric Name
    64764-335KAZANOalogliptin and metformin hydrochloride
    64764-337KAZANOalogliptin and metformin hydrochloride
    45802-169alogliptin and metformin hydrochloridealogliptin and metformin hydrochloride
    45802-211alogliptin and metformin hydrochloridealogliptin and metformin hydrochloride
    50090-5993alogliptin and metformin hydrochloridealogliptin and metformin hydrochloride

    Trademark Results [KAZANO]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    KAZANO
    KAZANO
    77223202 3717273 Live/Registered
    Takeda Pharmaceutical Company Limited
    2007-07-06
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.